ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Annexon, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$4.01+0.60 (+17.60%)
Close on Oct 19, 2026
- Market cap
- $806.02M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Annexon statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Annexon | Industry median |
|---|---|---|
| Market Cap | $819.82M | $166.30M |
| Enterprise Value | $610.62M | $88.19M |
| PB Ratio | 4.41 | 2.03 |
| P/TBV Ratio | 4.41 | 2.29 |
Income (trailing twelve months)
| Measure | Annexon | Industry median |
|---|---|---|
| Operating Income | -$210.56M | -$21.40M |
| Net Income | -$202.67M | -$22.46M |
| EBITDA | -$208.39M | -$16.91M |
| EPS (Diluted) | -$1.16 | -$0.83 |
Returns
| Measure | Annexon | Industry median |
|---|---|---|
| Return on Equity (ROE) | -105.3% | -53.2% |
| Return on Assets (ROA) | -79.4% | -40.9% |
| Return on Capital Employed (ROCE) | -101.4% | -38.1% |
Balance sheet
| Measure | Annexon | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $209.20M | $61.43M |
| Net Cash (Debt) | $209.20M | $15.35M |
| Net Cash Per Share | $1.02 | $0.66 |
| Equity (Book Value) | $186.06M | $49.09M |
| Book Value Per Share | $0.91 | $1.37 |
| Tangible Book Value | $186.06M | $23.52M |
| Working Capital | $174.28M | $76.81M |
Financial position
| Measure | Annexon | Industry median |
|---|---|---|
| Current Ratio | 5.53 | 3.34 |
| Quick Ratio | 5.44 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Annexon | Industry median |
|---|---|---|
| Operating Cash Flow | -$193.03M | -$12.35M |
| Capital Expenditures | -$185.00K | -$1.08M |
| Free Cash Flow | -$193.22M | -$20.22M |
| FCF Per Share | -$0.95 | -$0.42 |
Efficiency
| Measure | Annexon | Industry median |
|---|---|---|
| Profits Per Employee | -$2.11M | -$703.34K |
| Employee Count | 96 | 74 |
Dividends and yields
| Measure | Annexon | Industry median |
|---|---|---|
| Earnings Yield | -24.7% | -23.3% |
| FCF Yield | -23.6% | -8.72% |
| Dividend Yield | 0.00% | 1.82% |
| Buyback Yield | -11.5% | -0.59% |
| Shareholder Yield | -11.5% | 0.00% |
| Dividend Per Share | $0.00 | $0.83 |
| Years of Dividend Growth | 0 | 0 |
Shares
| Measure | Annexon | Industry median |
|---|---|---|
| Shares Outstanding | 204,445,000 | 58,127,000 |
| Shares Change (YoY) | 21.3% | 10.9% |
| Float | 192,657,000 | 49,136,700 |
| Shares Held by Insiders | 5.77% | 11.6% |
| Shares Held by Institutions | 87.2% | 59.4% |
Scores
| Measure | Annexon | Industry median |
|---|---|---|
| Altman Z-Score | 0.44 | -0.22 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from Annexon's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.